ResearcherShanxi Medical UniversityActive in the last 2 years
Gaopeng Li
Matched on ORCID iD 0000-0002-4128-1721; OpenAlex author ID A5006253019. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- A Chemotherapy Progression Decision Score for Treatment Selection After Initial Assessment in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70903↗
- MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy. Co-author DOI 10.1038/s43018-026-01236-w↗
- Untypical autoimmune pancreatitis and pancreatic cancer: differential diagnosis experiences extracted from misdiagnose of two cases. Co-author DOI 10.1186/s13023-019-1217-z↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daqian Xu · 2 shared papers, 2026 · strength 0.43
- Paper A Chemotherapy Progression Decision Score for Treatment Selection After Initial Assessment in Pancreatic Ductal Adenoca… DOI 10.1002/mco2.70903↗
- Paper MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy. DOI 10.1038/s43018-026-01236-w↗
- Yixin Zhang · 1 shared paper, 2026 · strength 0.24
- Yuan Ding · 1 shared paper, 2026 · strength 0.24
- Jieer Ying · 1 shared paper, 2026 · strength 0.24
- Weilin Wang · 1 shared paper, 2026 · strength 0.24
- Peixiang Zheng · 1 shared paper, 2026 · strength 0.20
- Qimin Zhou · 1 shared paper, 2026 · strength 0.20
- Jinfeng Ma · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.